Hydroxylamine
|
Basic information |
| Metabolite name | Hydroxylamine |
 | HMDB0003338 |
 |
C00192 |
 |
787 |
| Synonyms | NA |
| No. of studies | 12 |
|
Basic information |
| Metabolite name | Hydroxylamine |
| HMDB0003338 |
|
C00192 |
|
787 |
| Synonyms | NA |
| No. of studies | 12 |
|
Relationship between Hydroxylamine and depression (count: 12) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M010 | Type4 | SSRI-treated responder group vs. non-responder group | Plasma | Human | Up |
| Study M034 | Type1 | MDD group vs. control group | Urine | Human | Up |
| Study M042 | Type3 | fluoxetine group vs. control group | Plasma | Rhesus monkey | Down |
| Study M098 | Type1 | depressed group vs. control group | Peripheral blood mononuclear cell | Human | Up |
| Study M102 | Type1 | severe MDD group vs. control group | Urine | Human | Up |
| Study M116 | Type3 | LY group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M116 | Type3 | ketamine group vs. control group | Cerebrospinal fluid | Sprague-Dawley rat | Down |
| Study M116 | Type3 | ketamine group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M204 | Type1 | LPS group vs. control group | Hypothalamus | CD-1 mouse | Up |
| Study M536 | Type1 | naturally-occurring depression group vs. control group | Cerebrospinal fluid | Cynomolgus monkey | Up |
| Study M571 | Type1 | LPS group vs. control group | Hypothalamus | CD-1 mouse | Up |
| Study M668 | Type1 | PSD group vs. stroke group | Urine | Human | Down |
| Study M870 | Type2 | CRS + sertraline group vs. CRS group | Brain | C57BL/6 mouse | Up |
| Study M882 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M882 | Type1 | CUMS group vs. control group | Jejunum | Sprague-Dawley rat | Down |